4638 MYLK M NP_444253.3 n/d n/d n/d
476 Myosin Iβ (Nuclear) M3567 4641 MYO1C P NP_001074248.1 y y y
482 Myosin Va M4812 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y
483 Myosin Va M5062 4644 MYO5A
4638 MYLK M NP_444253.3 n/d n/d n/d
476 Myosin Iβ (Nuclear) M3567 4641 MYO1C P NP_001074248.1 y y y
482 Myosin Va M4812 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y
483 Myosin Va M5062 4644 MYO5A
4638 MYLK M NP_444253.3 n/d n/d n/d
476 Myosin Iβ (Nuclear) M3567 4641 MYO1C P NP_001074248.1 y y y
482 Myosin Va M4812 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y
483 Myosin Va M5062 4644 MYO5A
Negative Control NA
480 Anti Cy3+Cy5 C0992 M NA NA NA
481 Myosin Light Chain Kinase M7905 M y y Y
482 Myosin Va M4812 P n/d n/d y
483 Myosin Va M5062 P n/d n/d y
484 Myosin VI M0691 M y y y
485
Control NA
480 Anti Cy3+Cy5 C0992
481 Myosin Light Chain Kinase M7905 4638 MYLK NP_444260.1 M y y Y
482 Myosin Va M4812 25017, 17918, 4644 Myo5a,MYO5A NP_071514.1,NP_034994.2,NP_000250.2 P n/d n/d y
483
ITSFeeAkGLDRINeRMPPRRDAMP)
Specific calcineurin inhibitor. Corresponds to the C-terminal domain (residues 457-482) of
the calmodulin-binding domain of calcineurin (PP2B). Inhibits Mn2+-stimulated calcineurin
activity